26 April 2024: Aker BioMarine ASA ("Aker BioMarine" or "the company") reports
revenues of USD 78.3 million, up from USD 69.1 million last year. Adjusted
EBITDA was USD 15.2 million, up from USD 6.0 million same quarter last year. 

Highlights first quarter:
o Revenue of USD 78.3 million in the quarter, up 13% from USD 69.1 YoY
o Adjusted EBITDA of USD 15.2 million, up from USD 6.0 million YoY 
o The Adjusted EBITDA margin was 19% compared to 9% in the same quarter last
year
o Qrill Aqua sales increased by 33% and Superba krill oil sales increased by 11%
YoY 
o Krill offshore production volume of 21,306 MT, up 7% (19,852 MT)
o The drone was commissioned on the harvesting ground with proven ability to
identify krill
o Korean FDA awarded an additional health claim for skin health to Superba Krill
Oil
o The company has launched its new algae oil brand, FloraMarine
o The company announced a strategic review for the Feed Ingredients business.
o Aker BioMarine won the Norwegian Export Prize 2024


Aker BioMarine completed a company restructuring end of 2023 and has changed its
reporting format according to new business segments starting in Q1 2024. The
previous two segments (Ingredients and Brands) have been deconsolidated into
four new segments